Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, September 12, 2019
Catalent has announced professor David Schaffer has been appointed to the advisory board of the company’s biologics business.
read more
Thursday, September 12, 2019
Signant Health has been selected to provide electronic informed consent for a significant neuroscience study by the prestigious Shanghai Mental Health Center.
read more
Wednesday, September 11, 2019
McKesson and TrakCel announce a collaboration to support cell and gene therapy late-stage developers.
read more
Wednesday, September 11, 2019
Dr. Reddy’s Laboratories has announced the launch of Fosaprepitant for Injection, the therapeutic generic equivalent of EMEND® for injection, approved by the FDA.
read more
Wednesday, September 11, 2019
ABEC has introduced the Flexible Manufacturing Platform, a fully-customizable cell culture platform for flexible, high-volume biopharmaceutical production.
read more
Wednesday, September 11, 2019
Kinaxis will help Teva connect its data, processes and people into a single platform to transform its global supply chain, improve visibility and operational efficiencies.
read more
Wednesday, September 11, 2019
Tubulis and Glycotope announced that they have signed a research and feasibility agreement, providing Glycotope access to Tubulis’ proprietary antibody drug conjugate (ADC) technologies.
read more
Wednesday, September 11, 2019
Samsung Bioepis announced its expansion into the Brazilian biopharmaceutical market.
read more
Tuesday, September 10, 2019
AMRA has entered into an exclusive agreement with Micro, to guide and support pharmaceutical and research clients in Japan with clinical trials.
read more
Tuesday, September 10, 2019
The FDA’s compounding program aims to help protect patients from poor-quality compounded drugs, while preserving access to lawfully-marketed compounded drugs for patients who have a medical need for them.
read more
Tuesday, September 10, 2019
Experic has announced Denise Sabaday has been appointed vice president of business development.
read more
Tuesday, September 10, 2019
Nichi-Iko and Sagent announced their Canadian subsidiary, Omega Laboratories, has been found acceptable for manufacturing FDA-approved products.
read more
Tuesday, September 10, 2019
Albemarle Fine Chemistry Services announced the expansion of its operations at its Tyrone, Pennsylvania custom manufacturing facility.
read more
Monday, September 09, 2019
CMAB Biopharma announced a positive opinion in an external European quality audit conducted by Parexel International.
read more
Monday, September 09, 2019
Polpharma Biologics has entered a global commercialization agreement with Sandoz AG for a natalizumab biosimilar.
read more